Answers are grounded in this paper and cite their sources.
OBJECTIVES: To evaluate the effectiveness and safety of prophylactic inferior vena cava (IVC) filter in patients with hip fracture who were at high risk for pulmonary thromboembolism (PTE). METHODS: Design: Retrospective cohort study. SETTING: Single-center Level I Trauma Center. PATIENT SELECTION CRITERIA: Patients older than 50 years who sustained a low-energy hip fracture (AO/OTA 31A, B, and 32A) and underwent prophylactic IVC filter insertion before hip fracture surgery between 2005 and 2025 were included. Prophylactic IVC filter placement was selectively performed in patients with either objectively confirmed deep vein thrombosis on preoperative screening or absolute contraindications to mechanical and pharmacological venous thromboembolism prophylaxis. Those who had multiple trauma at the time of injury, a clinical follow-up duration ≤6 months after surgery, or undergone IVC filter placement following a confirmed diagnosis of PTE based on pulmonary computed tomography or lung perfusion scanning were excluded. OUTCOME MEASURES AND COMPARISONS: The primary outcome was the rate of newly developed symptomatic PTE. Secondary outcomes included IVC filter-related complications, retrieval rates, and 30-day mortality. RESULTS: One hundred fifty-six patients were included in the prophylactic IVC filter group (39 men 25.0%], 117 women [75.0%]; mean age, 75.8 ± 11.1 years; femoral neck [AO/OTA 31B], n = 71 [45.5%]; intertrochanteric [31A], n = 75 [48.1%]; subtrochanteric [AO/OTA 32A], n = 10 [6.4%];mean indwelling time, 9.1 days; retrieval rate, 88.5%). Among these patients, no cases of newly developed symptomatic PTE were observed (0%), whereas the incidence in the overall hip fracture cohort (n=4,568) was 0.44%. Filter-related complications occurred in 3.9% of patients (minor tilting, 2.6%; vessel adhesion, 1.3%), with no major mechanical failures such as migration or perforation. Although no thrombi were detected at insertion, 4.5% of the patients had trapped thrombi at the time of removal. The 30-day all-cause mortality rate was 1.3% (2/156) in the prophylactic IVC filter group, compared with 1.5% (67/4,568) in the overall hip fracture cohort. (p=0.845). Neither death in the prophylactic IVC filter group was attributed to PTE or an IVC filter-related complication. CONCLUSIONS: In this study's selected extreme pulmonary thromboembolism risk cohort, including patients with CT-confirmed preoperative DVT, those clinically expected to undergo prolonged perioperative immobilization, or those with contraindications to prophylactic anticoagulation, such as GI bleeding, prophylactic inferior vena cava filter served as an effective and safe temporary bridge therapy rather than a routine prophylactic strategy. LEVEL OF EVIDENCE: Prognostic Level III.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: